The effectiveness of the Sputnik V vaccine developed by Russia against the coronavirus was announced as 91.6 percent

A new type of coronavirus (Covid-19) vaccine called “Sputnik v” developed by the Russian Gamalea National Institute of Epidemiology and Microbiology was announced to have an efficiency rate of 91.6 percent in Phase 3 results.

Approved

The International Medical Journal, The Lancet, announced that the 91.6 percent effectiveness of the Sputnik v vaccine, which was undergoing Phase-3 Tests, had been confirmed.

Ian Jones, professor at the University of Reading and Polly Roy, of the London School of Hygiene and Tropical Medicine, said: “the development of the Sputnik v vaccine has been criticized for not being transparent. But the result is clear and scientific. Another vaccine has joined the coronavirus fight, ” he said.

IT SHOWED NO SERIOUS SIDE EFFECTS

The work was completed after months of work involving 19,866 volunteers, The Lancet said. While the vaccine was also effective on the elderly, “there were 2,144 volunteers over the age of 60 and 91.8 percent were effective in this group. It showed no serious side effects, ” the statement said.